Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation

Archives of Physical Medicine and Rehabilitation

Volumn 86, Issue 10, 2005, Pages 1941-1948

  Wilson, Richard D ^a,b   Murray, Patrick K ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Cost benefit analysis; Rehabilitation; Stroke; Venous thrombosis

Indexed keywords

ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; HEALTH CARE COST; HOSPITAL ADMISSION; MEDICAL DECISION MAKING; MODEL; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; SCREENING; SOCIAL ASPECT;

ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; LOWER EXTREMITY; MASS SCREENING; PATIENT ADMISSION; PULMONARY EMBOLISM; QUALITY-ADJUSTED LIFE YEARS; ULTRASONOGRAPHY, DOPPLER; UNITED STATES; VENOUS THROMBOSIS;

EID: 26444503709     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2005.05.009     Document Type: Article

References (54)

1. F.L. Silver, J.W. Norris, A.J. Lewis, V.C. Hachinski Early mortality following stroke a prospective review Stroke 15 1984 492 496
2. M. Viitanen, B. Winblad, K. Asplund Autopsy verified causes of death after stroke Acta Med Scand 222 1987 401 408
3. W.H. Geerts, J.A. Heit, G.P. Clagett Prevention of venous thromboembolism Chest 119 1 Suppl 2001 132S 175S
4. A.G. Turpie, M. Gent, R. Côte A low molecular weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke a randomized double-blind study Ann Intern Med 117 1992 353 357
5. M.J. Gitter, T.M. Jaeger, T.M. Petterson, B.J. Gersh, M.D. Silverstein Bleeding and thromboembolism during anticoagulant therapy a population-based study in Rochester, Minnesota Mayo Clin Proc 70 1995 806 808
6. C. Warlow, D. Ogston, A.S. Douglas Deep venous thrombosis of the legs after strokes Part II - Natural history BMJ 1 1976 1178 1183
7. J. Kelly, A. Rudd, R.R. Lewis, C. Coshall, A. Mody, B.J. Hunt Venous thromboembolism after acute stroke Stroke 32 2001 262 267
8. J.J. Byrne Phlebitis a study of 748 cases at Boston Hospital N Engl J Med 253 1995 579 586
9. R. Collins, A. Scrimgeour, S. Yusuf, R. Peto Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin N Engl J Med 318 1988 1162 1173
10. E.W. Salzman, G.C. Davies Prophylaxis of venous thromboembolism analysis of cost effectiveness Ann Surg 191; 1980 207 218
11. M.N. Levine, G. Raskob, J. Hirsh Hemorrhagic complications of long-term anticoagulant therapy Chest 119 2001 S108 S121
12. R. Hull, T. Delmore, E. Genton Warfarin sodium versus low dose heparin in the long term treatment of venous thrombosis N Engl J Med 301 1979 855 858
13. L.J. Bynum, J.E. Wilson Low-dose heparin therapy in the long-term management of venous thromboembolism Am J Med 67 1979 553 556
14. M.N. Levine, G. Raskob, R.J. Beyth, C. Kearon, S. Schulman Hemorrhagic complications of anticoagulant treatment. The Seventh ACCP Conference of Antithrombotic and Thrombolytic Therapy Chest 126 Suppl 2004 287S 310S
15. L. Linkins, P.T. Choi, J.D. Douketis clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism Ann Intern Med 139 2003 893 900
16. J.D. Douketis, G.A. Foster, M.A. Crowther, M.H. Prins, J.S. Ginsberg Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy Arch Intern Med 160 2000 3431 3436
17. C.S. Landefeld, L. Goldman Major bleeding in outpatients treated with warfarin incidence and prediction by factors known at the start of outpatient therapy Am J Med 87 1989 144 152
18. G. Pambianco, T. Orchard, P. Landau Deep vein thrombosis prevention in stroke patients during rehabilitation Arch Phys Med Rehabil 76 1995 324 330
19. E.R. Sioson, W.E. Crowe, N.V. Dawson Occult proximal deep vein thrombosis its prevalence among patients admitted to a rehabilitation hospital Arch Phys Med Rehabil 69 1988 183 185
20. M. Desmukh, M. Bisignana, P. Landau, T.J. Orchard Deep vein thrombosis in rehabilitating stroke patients Am J Phys Med Rehabil 70 1991 313 316
21. C. Cope, T.M. Reyes, N.J. Skversky plebographic analysis of the incidence of thrombosis in hemiplegia Radiology 109 1973 581 584
22. A.T. Miyamoto, L.S. Miller Pulmonary embolism in stroke prevention by early heparinization of venous thrombosis detected by iodine-125 fibrinogen leg scans Arch Phys Med Rehabil 61 1980 584 587
23. M. Hillbom, T. Erilä, K. Sotaniemi, T. Tatlismak, S. Sarna, M. Kaste Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke a randomized, double-blind study Acta Neurol Scand 106 2002 84 92
24. M.E. Brandstater, E.J. Roth, H.C. Siebens Venous thromboembolism in stroke literature review and implications for clinical practice Arch Phys Med Rehabil 73 5 Suppl 1992 S379 S391
25. C. Warlow, D. Ogston, A.S. Douglas Deep venous thrombosis of the legs after strokes. Part I - Incidence and predisposing factors BMJ 1 1976 1178 1183
26. R.L. Harvey, E.J. Roth, P.R. Yarnold, J.R. Durham, D. Green Deep vein thrombosis in stroke the use of plasma D-dimer level as a screening test in the rehabilitation setting Stroke 27 1996 1516 1520
27. C. Kearon, J.A. Julian, T.E. Newman, J.S. Ginsberg Noninvasive diagnosis of deep venous thrombosis Ann Intern Med 128 1998 6633 6677
28. J.M. Meythaler, M.J. DeVivo, J.B. Hayne Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation Arch Phys Med Rehabil 77 1996 1 5
29. V. Kadyan, D.M. Clinchot, S.C. Colachis Cost-effectiveness of duplex ultrasound surveillance in spinal cord injury Am J Phys Med Rehabil 83 2004 191 197
30. R.L. Harvey, L.L. Lovell, N. Belanger, E.J. Roth The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation a historical cohort study Arch Phys Med Rehabil 85 2004 1070 1075
31. P. Mismetti, S. Laporte-Simitsidis, B. Tardy Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins a meta-analysis of randomised clinical trials Thromb Haemost 83 2000 14 19
32. Health Care Financing Administration Discharges, total days of care, and average charge for discharge, for Medicare beneficiaries discharged from short-stay hospitals, by leading diagnosis-related groups for 1996 CY 1984, 1990, 1996 Health Care Financ Rev 20 Suppl 1998 224 229
33. J. Kelly, A. Rudd, R.R. Lewis, B.J. Hunt Screening for subclinical deep-vein thrombosis Q J Med 94 2001 511 519
34. W.H. Geerts, G.F. Pineo, J.A. Heit Prevention of venous thromboembolism the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 338S 400S
35. P. Stein Pulmonary embolism 1997 Wilkins & Wilkins Baltimore
36. The PIOPED Investigators Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED) JAMA 263 1990 2753 2759
37. A.S. Gallus, J. Hirsh Treatment of venous thromboembolic disease Semin Thromb Hemost 2 1976 291 331
38. P.D. Stein, J.W. Henry, B. Relyea untreated patients with pulmonary embolism outcome, clinical, and laboratory assessment Chest 107 1995 931 935
39. L.C. Carson, M.A. Kelley, A. Duff The clinical course of pulmonary embolism N Engl J Med 326 1992 1240 1245
40. J.D. Douketis, C. Kearon, S. Bates, E.K. Duku, J.S. Ginsberg Risk of fatal pulmonary embolism in patients with treated venous thromboembolism JAMA 279 1998 458 462
41. S.T. McCarthy, J. Turner Low dose subcutaneous heparin in the prevention of deep vein thrombosis and pulmonary embolus following acute stroke Age Ageing 15 1986 84 88
42. M. Marchetti, A. Pistorio, M. Barone, S. Serafini, G. Barosi Low-molecular-weight heparin vs. warfarin for secondary prophylaxis of venous thromboembolism a cost-effectiveness analysis Am J Med 111 2001 130 139
43. Archived consumer price index detailed report tables 2005 US Department of Labor, Bureau of Labor Statistics Washington (DC) April, Available at: http://www.bls.gov/cpi/cpid0504.pdf. Accessed June 3, 2005
44. Centers for Medicare and Medicaid Services. Clinical Diagnostic Laboratory Fee Schedule and National Physician Fee Schedule. Available at: http://cms.hhs.gov/data/download/default.asp. Accessed June 2, 2005.
45. Drug topics red book 2004 Medical Economics Montvale
46. J.A. O'Brien, J.J. Caro Direct Medical cost of managing deep vein thrombosis according to the occurrence of complications Pharmacoeconomics 20 2002 603 615
47. A.D. Auerbach, G.D. Sanders, J. Hambleton Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis Am J Med 116 2004 816 828
48. F. Sarsin, H. Bounameaux Antithrombotic strategy after total hip replacement a cost-effectiveness analysis comparing prolonged oral anticoagulants with screening for deep vein thrombosis Arch Intern Med 156 1996 1661 1668
49. J.H. You, F.W. Chang, R.S. Wong, G. Cheng Cost-effectiveness of two models of management for patients on chronic warfarin therapy - a Markov model analysis Thromb Haemost 90 2003 1106 1111
50. M.H. Eckman, H.J. Levine, D.N. Salem, S.G. Pauker Making decisions about antithrombotic therapy in heart disease decision analytic and cost-effectiveness issues Chest 114 5 Suppl 1998 699S 714S
51. D.M. Bravata, S.Y. Ho, L.M. Brass, J. Concato, J. Scinto, T. Meehan Long-term mortality in cerebrovascular disease Stroke 34 2003 699 704
52. K. Hardie, G.J. Hankey, K. Jamrozik, R.J. Broadhurst, C. Anderson Ten-year survival after first-ever stroke in the Perth community stroke study Stroke 34 2003 1842 1846
53. B. Indredavik, F. Bakke, S.A. Slordahl, R. Rokseth, L.L. Haheim Stroke unit treatment 10-year follow-up Stroke 30 1999 1524 1527
54. J.W. Sturm, G.A. Donnan, H.M. Dewey Quality of life after stroke the North East Melbourne Stroke Incidence Study (NEMESIS) Stroke 35 2004 2340 2345